Faculty Profiles - NAKAYAMA Goro

Papers - NAKAYAMA Goro

Division display 81 - 100 of about 152 ／ All the affair displays >>

Randomized phase II trial of CAPOX with continuous versus intermittent use of oxaliplatin as an adjuvant chemotherapy after curative resection of stage II/III colon cancer (CCOG-1302 study)

Nakamura, M; Nakayama, G; Ishigure, K; Mashita, N; Yokoyama, H; Hattori, N; Uehara, K; Yamada, S; Koike, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 38 ( 4 ) 2020.2

Predictive value of the modified systemic inflammation score in patients undergoing curative resection of squamous cell carcinoma of the esophagus

Kanda, M; Koike, M; Shimizu, D; Tanaka, C; Kobayashi, D; Sonohara, F; Takami, H; Inokawa, Y; Hattori, N; Hayashi, M; Yamada, S; Nakayama, G; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 38 ( 4 ) 2020.2

A prospective trial to evaluate treatment effects of a β-hydroxy-β-methylbutyrate containing nutrient for leakage a the anastomotic site after esophagectomy

Kanda, M; Koike, M; Fukaya, M; Miyata, K; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Murotani, K; Fujiwara, M; Nagino, M; Kodera, Y

NAGOYA JOURNAL OF MEDICAL SCIENCE Vol. 82 ( 1 ) page： 33 - 37 2020.2

The Significance of Molecular Biomarkers on Clinical Survival Outcome Differs Depending on Colon Cancer Sidedness

Hirabayashi, S; Hayashi, M; Nakayama, G; Mii, S; Hattori, N; Tanabe, H; Kanda, M; Tanaka, C; Kobayashi, D; Yamada, S; Koike, M; Fujiwara, M; Takahashi, M; Kodera, Y

ANTICANCER RESEARCH Vol. 40 ( 1 ) page： 201 - 211 2020.1

Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)

Hattori, N; Nakayama, G; Uehara, K; Aiba, T; Ishigure, K; Sakamoto, E; Tojima, Y; Kanda, M; Kobayashi, D; Tanaka, C; Yamada, S; Koike, M; Fujiwara, M; Nagino, M; Kodera, Y

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY Vol. 25 ( 1 ) page： 118 - 125 2020.1

Peritoneal Lavage Tumor DNA as a Novel Biomarker for Predicting Peritoneal Recurrence in Pancreatic Ductal Adenocarcinoma

Suenaga, M; Fujii, T; Yamada, S; Hayashi, M; Shinjo, K; Takami, H; Niwa, Y; Sonohara, F; Shimizu, D; Kanda, M; Kobayashi, D; Tanaka, C; Nakayama, G; Koike, M; Fujiwara, M; Kondo, Y; Kodera, Y

PANCREAS Vol. 48 ( 10 ) page： 1528 - 1528 2019.11

Comparison of non-invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma

Sonohara, F; Yamada, S; Tanaka, N; Tashiro, M; Sunagawa, Y; Morimoto, D; Tanaka, H; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

HEPATOLOGY RESEARCH Vol. 49 ( 11 ) page： 1305 - 1315 2019.11

Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines

Miwa, T; Kanda, M; Umeda, S; Tanaka, H; Shimizu, D; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

IN VIVO Vol. 33 ( 6 ) page： 1785 - 1792 2019.11

Expression, Function, and Prognostic Value of MAGE-D4 Protein in Esophageal Squamous Cell Carcinoma

Uno, Y; Kanda, M; Sato, Y; Shimizu, D; Umeda, S; Hattori, N; Hayashi, M; Tanaka, C; Kobayashi, D; Yamada, S; Nakayama, G; Motoyama, S; Koike, M; Kodera, Y

ANTICANCER RESEARCH Vol. 39 ( 11 ) page： 6015 - 6023 2019.11

Level of Melanotransferrin in Tissue and Sera Serves as a Prognostic Marker of Gastric Cancer

Sawaki, K; Kanda, M; Umeda, S; Miwa, T; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Koike, M; Kodera, Y

ANTICANCER RESEARCH Vol. 39 ( 11 ) page： 6125 - 6133 2019.11

Feasibility of subtotal esophagectomy with systematic lymphadenectomy in selected elderly patients with esophageal cancer; a propensity score matching analysis

Kanda, M; Koike, M; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Omae, K; Kodera, Y

BMC SURGERY Vol. 19 ( 1 ) page： 143 2019.10

Randomized phase II trial of CAPOX with planned oxaliplatin stop-and-go strategy as adjuvant chemotherapy after curative resection of colon cancer (CCOG-1302 study)

Yokoyama, H; Nakayama, G; Ishigure, K; Hayashi, N; Tanaka, K; Tsutsuyama, M; Hattori, N; Yamada, S; Kodera, Y

ANNALS OF ONCOLOGY Vol. 30 2019.10

Novel implications of combined arterial resection for locally advanced pancreatic cancer in the era of newer chemo-regimens

Sonohara, F; Yamada, S; Takami, H; Hayashi, M; Kanda, M; Tanaka, C; Kobayashi, D; Nakayama, G; Koike, M; Fujiwara, M; Fujii, T; Kodera, Y

EJSO Vol. 45 ( 10 ) page： 1895 - 1900 2019.10

Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer.

Kato Y, Yamada S, Tashiro M, Sonohara F, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y

HPB : the official journal of the International Hepato Pancreato Biliary Association Vol. 21 ( 9 ) page： 1211 - 1218 2019.9

Functions of FRAS1 as a driver gene of liver metastasis from gastric cancer analyzed by the genome editing technology

Umeda, S; Kanda, M; Tanaka, H; Sonohara, F; Takami, H; Hattori, N; Hayashi, M; Tanaka, C; Kobayashi, D; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

CANCER RESEARCH Vol. 79 ( 13 ) 2019.7

Albumin-Bilirubin Score Predicts Tolerability to Adjuvant S-1 Monotherapy after Curative Gastrectomy

Miwa, T; Kanda, M; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Kodera, Y

JOURNAL OF GASTRIC CANCER Vol. 19 ( 2 ) page： 183 - 192 2019.6

Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.

Miwa T, Kanda M, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y

Annals of surgical oncology Vol. 26 ( 5 ) page： 1535 - 1543 2019.5

Neoadjuvant CAPOX and bevacizumab alone for locally advanced rectal cancer: long-term results from the N-SOG 03 trial.

Tomida A, Uehara K, Hiramatsu K, Maeda A, Sakamoto E, Okada Y, Kurumiya Y, Nakayama G, Nakamura M, Aiba T, Nagino M, Of the Nagoya Surgical Oncology Group.

International journal of clinical oncology Vol. 24 ( 4 ) page： 403 - 410 2019.4

Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer

Uno Yasuo, Kanda Mitsuro, Miwa Takashi, Umeda Shinichi, Tanaka Haruyoshi, Tanaka Chie, Kobayashi Daisuke, Suenaga Masaya, Hattori Norifumi, Hayashi Masamichi, Yamada Suguru, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

ANNALS OF SURGICAL ONCOLOGY Vol. 26 ( 3 ) page： 836 - 844 2019.3

Prediction of peritoneal recurrences of gastric cancer by qPCR analysis of peritoneal lavage fluids.

Nakanishi, K; Kanda, M; Umeda, S; Tanaka, C; Kobayashi, D; Hayashi, M; Yamada, S; Nakayama, G; Koike, M; Fujiwara, M; Kodera, Y

JOURNAL OF CLINICAL ONCOLOGY Vol. 37 ( 4 ) 2019.2

　 PREV - NEXT 　

<NAKAYAMA Goro>

Papers - NAKAYAMA Goro